| 000 | 01716 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250511180037.0 | ||
| 264 | 0 | _c19920616 | |
| 008 | 199206s 0 0 eng d | ||
| 022 | _a0022-538X | ||
| 024 | 7 |
_a10.1128/JVI.66.6.3616-3623.1992 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVlach, J | |
| 245 | 0 | 0 |
_aHerpes simplex virus type 1-mediated induction of human immunodeficiency virus type 1 provirus correlates with binding of nuclear proteins to the NF-kappa B enhancer and leader sequence. _h[electronic resource] |
| 260 |
_bJournal of virology _cJun 1992 |
||
| 300 |
_a3616-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xmicrobiology |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aDNA, Recombinant |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xmetabolism |
| 650 | 0 | 4 |
_aHIV Enhancer _xphysiology |
| 650 | 0 | 4 |
_aHIV Long Terminal Repeat _xphysiology |
| 650 | 0 | 4 |
_aHIV-1 _xgrowth & development |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 |
_aNuclear Proteins _xmetabolism |
| 650 | 0 | 4 | _aPromoter Regions, Genetic |
| 650 | 0 | 4 |
_aProviruses _xgrowth & development |
| 650 | 0 | 4 |
_aSimplexvirus _xmetabolism |
| 650 | 0 | 4 |
_aT-Lymphocytes _xmicrobiology |
| 650 | 0 | 4 |
_aTetradecanoylphorbol Acetate _xpharmacology |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xpharmacology |
| 650 | 0 | 4 |
_aVirus Activation _xdrug effects |
| 700 | 1 | _aPitha, P M | |
| 773 | 0 |
_tJournal of virology _gvol. 66 _gno. 6 _gp. 3616-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/JVI.66.6.3616-3623.1992 _zAvailable from publisher's website |
| 999 |
_c1322993 _d1322993 |
||